4.6 Article

CRISPR/Cas9 gene editing in the West Nile Virus vector, Culex quinquefasciatus Say

Journal

PLOS ONE
Volume 14, Issue 11, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0224857

Keywords

-

Funding

  1. DARPA's Safe Genes program [N66001-17-2-4054]
  2. Wellcome Trust [200171/Z/15/Z]
  3. UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/I/00007033, BBS/E/I/00007038, BBS/E/I/00007039]
  4. Wellcome Trust [200171/Z/15/Z] Funding Source: Wellcome Trust
  5. BBSRC [BBS/E/I/00007039, BBS/E/I/00007033, BBS/E/I/00007038] Funding Source: UKRI

Ask authors/readers for more resources

Culex quinquefasciatus Say is an opportunistic blood feeder with a wide geographic distribution which is also a major vector for a range of diseases of both animals and humans. CRISPR/Cas technologies have been applied to a wide variety of organisms for both applied and basic research purposes. CRISPR/Cas methods open new possibilities for genetic research in non-model organisms of public health importance. In this work we have adapted microinjection techniques commonly used in other mosquito species to Culex quinquefasciatus, and have shown these to be effective at generating homozygous knock-out mutations of a target gene in one generation. This is the first description of the kmo gene and mutant phenotype in this species.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available